pharmaphorum

NOVEMBER 9, 2021

This webinar will take place on Tuesday 9th November at 12:00 pm GMT / 1:00 pm CET. This webinar will share more information about how to work more collegially with academics, industry and patient groups to ultimately improve the care and treatment of patients with rare diseases.

Drug Development 52

Drug Development 52

Safe Biologics

JUNE 12, 2023

Coming Soon: ASBM/GaBI Webinar on IRA’s Medicare Price Negotiation Provisions ASBM and the Generics and Biosimilars Initiative (GaBI) are in the final planning stages for the first of two webinars examining the implications for patients and healthcare providers of the recently-passed Inflation Reduction Act (IRA).

Biosimilars 100

Biosimilars Drug Pricing Compounding Drug Development 100

PharmaTech

MARCH 13, 2024

Webinar Date/Time: Wed, Apr 24, 2024 11:00 AM EDT

Drug Development 52

Drug Development 52

PharmaTech

JUNE 6, 2023

Webinar Date/Time: Tuesday, June 27th, 2023 at 8am EDT | 1pm BST | 2pm CEST | 5am PDT Wednesday, June 28th, 2023 at 8am EDT | 1pm BST | 2pm CEST | 5am PDT Thursday, June 29th, 2023 at 8am EDT | 1pm BST | 2pm CEST | 5am PDT

Drug Development 52

Drug Development 52

pharmaphorum

MARCH 10, 2017

With market access being referred to as the “fourth hurdle” in drug development (beyond efficacy, safety and quality), it is vital that the requirements for both approval and access are addressed early in the process.

Drug Development 52

Drug Development 52

PharmaTech

MAY 17, 2023

Webinar Date/Time: Wed, Jun 14, 2023 11:00 AM EDT

Drug Development 52

Drug Development 52

PharmaTech

NOVEMBER 21, 2022

Webinar Date/Time: Mon, Dec 12, 2022 11:00 AM EST.

Drug Development 52

Drug Development 52

Pharma Marketing Network

MARCH 13, 2025

Email marketing campaigns can keep healthcare professionals informed about drug developments. Podcasts and webinars allow industry experts to provide in-depth insights about medications. Physician networking webinars discussing treatment advancements. SEO-optimized blog content helps brands rank higher in search results.

Drug Pricing 59

Drug Pricing Online Pharmacies Drug Development 59

pharmaphorum

NOVEMBER 27, 2020

New models of drug development are fuelling life-changing advantages in the rare disease space, previously an economic no-go area for pharma and biotech companies. That was among the discussion points during Fighting Rare Diseases – The Science, Economics and the Patients , a webinar hosted by o2h Group.

Drug Development 132

Drug Development 132

pharmaphorum

FEBRUARY 1, 2022

This webinar will also explore: (two or three bullet points). He has carried a drug candidate continuously from early preclinical development throughout to market authorisation with an innovative application strategy, including a novel and innovative real-world data approach. Designing and generating a synthetic control arm.

Drug Development 104

Drug Development 104

Safe Biologics

OCTOBER 10, 2023

Clip 4: Panel Discussion – View clip. Full Webinar – View the full webinar here. FDA Approves First U.S. Read the full ASBM Statement here. – View clip.

Biosimilars 130

Biosimilars Drug Pricing Drug Development 130

Pharma Leaders

MAY 12, 2023

Each business day, FDAnews provides valuable insights into: Best practices in regulatory compliance and the pathways to approval Draft and final guidances from the FDA and other regulatory agencies Company mergers and technology developments FDA budgets and spending, including proposals and approvals by Congress and the President Quality and GMP regulatory (..)

Drug Development 52

Drug Development Documentation 52

Safe Biologics

NOVEMBER 12, 2023

View the full webinar here or watch individual segments linked below. Financing additional research and development into existing treatments will be difficult to justify. View ASBM’s recent webinar on the IRA’s effects here. Read the full op-ed here. Missed last month’s ASBM Newsletter? Read it here.

Biosimilars 130

Biosimilars Drug Pricing Packaging Labelling 130

PharmaTech

NOVEMBER 14, 2022

Tuesday, November 15th, 2022 at 10 am EDT | 8 am CDT | 7 am PD Spatial Biology is changing the drug development landscape. Join the webinar on November 15th to learn more about the solutions Spatial Biology provides.

Drug Development 52

Drug Development 52

Big Molecule Watch

SEPTEMBER 14, 2023

Click here to register for the webinar. The post Legal Challenges to the Inflation Reduction Act: An Update on Pending Challenges and Reactions to Oral Argument in Dayton Area Chamber Of Commerce et al.

Drug Pricing 53

Drug Pricing Drug Development 53

Pharmaceutical Technology

OCTOBER 26, 2022

On October 6, in a GlobalData webinar, experts tried to answer the question ‘ Is Pharma at an ESG turning point?’ , revealing a multitude of diverse strategies for pharmaceutical companies to remain conscious of their global impacts. Major inequities are seen in drug development, hospital treatment, and insurance coverage.

Pharmaceutical Companies 64

Pharmaceutical Companies Pharmaceutical Companies Hospitals Drug Development 64

Safe Biologics

DECEMBER 8, 2022

The presentation reflected the findings from a recent webinar ASBM held on this subject with GaBI Journal. Among the factors identified in the webinar were the ability for physicians to choose freely between multiple products- innovators and biosimilars- when prescribing. Read the GaBI Journal report of the webinar here.

Biosimilars 100

Biosimilars Communication Drug Development 100

pharmaphorum

FEBRUARY 11, 2016

The first in a trilogy of webinars focussed on the topic; Unlocking the value; the economic equation and part of the IMS Health Practical Insights series. Answering this paradigm is where real world evidence can step in.

Drug Development 52

Drug Development 52

Safe Biologics

DECEMBER 6, 2023

BioSpace previously reported Meenakshi Datta, a partner at Chicago-based law firm Sidley Austin, argued that the IRA might also adversely affect orphan drug development. Watch clips from the webinar here. Read the full BioSpace article here. Missed last month’s ASBM Newsletter?

Biosimilars 130

Biosimilars Packaging Labelling Drug Development 130

Express Pharma

OCTOBER 19, 2024

Arora explains that pharma associations like the Indian Pharmaceutical Association (IPA) organise training and development programmes through sessions, workshops, and webinars focused on the latest trends and technologies in R&D.

Drug Development 111

Drug Development Documentation 111

pharmaphorum

AUGUST 24, 2022

Speakers at a recent Patients as Partners webinar on the document welcomed its publication, and explained how community and collaboration were the keys to turning theory into practice. How do you create better efficacy in the drugs that are being prescribed to work in a black body, at the cellular level?” Why, not how.

Documentation 111

Documentation Drug Development 111

Pharma Marketing Network

NOVEMBER 15, 2024

Table of Contents Sr# Headings 1 Leverage Virtual Platforms 2 Participate in Pharma-Focused Webinars 3 Engage on Social Media 4 Create Valuable Content 5 Attend Local Meetups 6 Optimize Your LinkedIn Profile 7 Network at Trade Shows 8 Collaborate on Research 9 Subscribe to Industry Newsletters 10 Use Affordable CRM Tools 1.

Drug Development 40

Drug Development 40

Pharma Marketing Network

FEBRUARY 27, 2025

Webinars & Virtual Conferences HCPs value expert insights and peer discussions. Hosting webinars with leading researchers, KOLs (Key Opinion Leaders), and medical professionals enhances credibility. Behind-the-scenes research lab videos showcasing drug development. Medication trackers & digital health guides.

Biosimilars 52

Biosimilars Communication Diabetes Drug Development 52

Definitive Healthcare

JUNE 29, 2023

Resource Type E-Books & How-To Guides Blog Special Report Webinar A (friendly) ghost in the machine: Exploring AI in medical devices AI in healthcare study AI and machine learning in healthcare Image Image Image ","nextArrow":" ","appendArrows":".coh-slider-nav-bottom","dots":false,"draggable":true,"swipe":true,"fade":false,"vertical":false,"speed":700,"cssEase":"ease","pauseOnHover":false,"pauseOnDotsHover":false,"autoplay":false,"rows":0},"sm":{"slidesToShow":2,"arrows":true,"prevArrow"

Drug Development 52

Drug Development 52

Pharmaceutical Technology

NOVEMBER 2, 2022

Webinars became a popular option during the pandemic, especially due to the ability to widen their reach through a recording which can then be split into smaller, more convenient fragments. These webinar and group meeting systems are an evolving sector. Online discussion forums can also be a great place for collaboration to flourish.

Communication 52

Communication Drug Development 52

Viseven

AUGUST 15, 2024

The traditional model of drug development and healthcare delivery is undergoing a seismic shift, with patient engagement emerging as a critical factor in achieving better health outcomes and driving innovation. This change is further driven by major regulatory bodies emphasizing Patient-Focused Drug Development (PFDD).

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Drug Development 52

Pharmaceutical Technology

FEBRUARY 13, 2023

Given the plethora of new chemical entity (NCE) candidates, pharmaceutical research groups frequently face challenges when selecting the most promising candidate for development purposes. With all this in mind, how do drug developers know which strategy and approach is right for their molecule at this early stage?

Compounding 52

Compounding Drug Development Dosage 52

pharmaphorum

JANUARY 26, 2022

With drawn-out timelines and billions in investments, traditional clinical trial methods are increasingly a barrier to cost-efficient and timely drug development. Clinical trials are involved, expensive, and have been done largely the same way for decades but with today’s technology all that can change.

Drug Development 52

Drug Development 52

Pharma Marketing Network

OCTOBER 24, 2024

Whether it’s through webinars, mobile apps, email campaigns, or in-person conferences, consistency is key. Companies that commit to green practices and ethical drug development are more likely to win the loyalty of both healthcare professionals and patients.

Diabetes 52

Diabetes Drug Development 52

Pharma Marketing Network

JANUARY 29, 2025

With machine learning and big data analytics, companies can now predict market trends, enhance drug development, and create hyper-personalized campaigns. A great example is how Merck and AstraZeneca use AI-driven content to engage physicians via targeted LinkedIn campaigns, automated email sequences, and interactive medical webinars.

Communication 52

Communication Drug Development 52

Viseven

NOVEMBER 9, 2022

Key Opinion Leaders play a critical role in the life sciences industry – pharmaceutical companies often engage them during clinical trials and drug commercialization. However, given the current regulatory approval challenges, many pharma companies seek to collaborate with KOLs medical throughout the entire drug development cycle.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Drug Development 52

Putting Patients First Blog

JANUARY 30, 2024

We also offered webinars highlighting key expertise within membership, including the pharmacy community, medical device and technology sector, and health care payers. In addition, PDUFA VII implementation is underway, with key NHC-supported patient engagement initiatives. What’s more?

Communication 52

Communication Drug Development 52

Putting Patients First Blog

APRIL 30, 2024

This could include workshops, webinars, and online resources that provide insights into cultural competence in research settings. To support these enhancements, the NHC recommends the development of a comprehensive training module for IRB members and ethics committees that covers the nuances of evaluating informed consent materials.

Documentation 52

Documentation Communication Mayo Clinic Drug Development 52

European Pharmaceutical Review

DECEMBER 19, 2024

Researchers are very aware that poor quality inputs can lead to inaccurate and biased AI outputs, which can have huge consequences in a field such as drug development, where patient health is at stake. AI/ML Webinar Trustworthy AI. Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence.

Drug Development 98

Drug Development 98

Pharmaceutical Technology

FEBRUARY 23, 2023

As formulators, we are often able to directly impact the amount of drug absorbed through formulation optimization and improve exposure. However, the chances of improving the exposure profile of a drug that is highly cleared by formulation modification are limited. S54 – S61 (2001).

Drug Development 98

Drug Development Compounding Dosage Packaging 98

Safe Biologics

SEPTEMBER 11, 2023

On July 26 th , ASBM hosted a webinar with the Generics and Biosimilars Initiative (GaBI) to examine the price-setting policy’s impact on drug development and reduced patient access to new medicines.

Drug Pricing 150

Drug Pricing Biosimilars Vaccines Drug Development 150

Pharmaceutical Technology

MARCH 22, 2023

Several drug development trends are driving injectables demand. This includes the rising number of biologic drugs on the market, which are mostly administered parenterally. This on-demand webinar discusses the importance of a patient-appropriate BL & GF profile. Please check your email to download the Webinar.

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52